Literature DB >> 6620148

Stereospecific high-performance liquid chromatographic analysis of warfarin in plasma.

C Banfield, M Rowland.   

Abstract

A stereospecific high-performance liquid chromatographic assay has been developed to determine R(+)- and S(-)-warfarin simultaneously in plasma. The method involved the formation of diastereoisomeric esters, using carbobenzyloxy-L-proline, with subsequent separation using silica as the stationary phase. The method permits characterization of the pharmacokinetics of warfarin enantiomers following administration of racemic drug.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6620148     DOI: 10.1002/jps.2600720820

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

Review 1.  Enantiomeric resolution of drug compounds by liquid chromatography.

Authors:  H T Karnes; M A Sarkar
Journal:  Pharm Res       Date:  1987-08       Impact factor: 4.200

2.  The measurement of warfarin enantiomers in serum using coupled achiral/chiral, high-performance liquid chromatography (HPLC).

Authors:  Y Q Chu; I W Wainer
Journal:  Pharm Res       Date:  1988-10       Impact factor: 4.200

3.  Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin.

Authors:  E Chan; A J McLachlan; M Pegg; A D MacKay; R B Cole; M Rowland
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

4.  Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity.

Authors:  H H Thijssen; L G Baars; H T Vervoort-Peters
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.